Can immunotherapy help before bladder surgery?

Question

Hello doctor,

My father was recently diagnosed with high-grade muscle-invasive bladder cancer. His CT urogram showed a tumor measuring about 1.38 inches on the left bladder wall, and urine cytology confirmed malignant cells.

The urologist has recommended radical cystectomy, but we are still exploring chemotherapy before surgery. His kidney function is normal (creatinine 0.9 mg/dL), but his hemoglobin has dropped to 9.2 g/dL, and he feels fatigued.

We want to know the following:

Are there newer treatments like immunotherapy that can help improve survival before surgery?
Should we ask for PD-L1 testing?
What are the chances of bladder preservation if we choose chemoradiation instead of surgery?

Please suggest.

Thank you.

Answer 1

Hello,

Welcome to icliniq.com.

Thank you for reaching out.

I truly appreciate you trusting me with these details. I understand how stressful this situation must be for you and your family.

When a loved one is diagnosed with a serious condition, it is completely natural to feel worried and overwhelmed. You have taken an important and responsible step by seeking guidance, and I will do my best to help you understand this clearly with safe, evidence-based information.

From what you have described, your father has been diagnosed with high-grade, muscle-invasive bladder cancer (a more aggressive and advanced type of bladder cancer that needs prompt and strong treatment).

The imaging report shows a 1.38-inch tumor on the left bladder wall, and urine cytology has confirmed the presence of malignant cells. The good news is that his kidney function is normal. However, he currently has mild anemia (Hb 9.2 g/dL), which could explain his fatigue and low energy levels.

Since you are considering chemotherapy before surgery, along with newer options such as immunotherapy and bladder-preserving treatments, you are thinking in the right direction. For cases like this, treatment usually depends on overall health status, tumor behavior, and patient preference, and is best planned by a multidisciplinary team.

The anemia and fatigue may be related to several factors, including:

Cancer-related anemia can occur due to chronic disease effects or bone marrow suppression.
Nutritional deficiencies or possible microscopic blood loss.
Other underlying medical conditions (these are less likely but should still be checked).

To guide treatment more precisely, it would be helpful to review your father’s complete blood count trends along with iron profile, liver and kidney function tests, detailed CT (computerized tomography) or MRI (magnetic resonance imaging) imaging reports, and any previous biopsy or pathology slides, as these reports provide important information about the severity of anemia, overall organ function, and the exact characteristics of the tumor.

Other causes of similar urinary findings are uncommon but can include infections, urinary stones, or other urological cancers. A confirmed diagnosis depends primarily on pathology combined with imaging findings, and based on the information available, high-grade muscle-invasive bladder cancer remains the most likely diagnosis.

Based on your father’s condition, treatment options will be discussed carefully by his oncology and urology team, taking into account his overall health, kidney function, and personal preferences.

Radical cystectomy, which is the surgical removal of the bladder, is often considered the standard curative treatment for aggressive muscle-invasive bladder cancer when the patient is medically fit for surgery.
Neoadjuvant chemotherapy (which means giving chemotherapy before the main cancer treatment) before surgery may be recommended in some patients, as it can help improve long-term survival outcomes, especially if kidney function is good and the patient can tolerate chemotherapy.
Immunotherapy (a type of cancer treatment that helps the body’s own immune system fight cancer cells more effectively) is usually used in advanced or metastatic cases, but in some situations, it may be considered through clinical trials depending on specific molecular markers such as PD-L1 (programmed death-ligand 1) status.
Bladder-preserving chemoradiation (a treatment approach that uses both chemotherapy and radiation therapy together to treat bladder cancer while trying to keep the bladder intact) may be considered if surgery is not possible or if the patient prefers to keep the bladder, but this option requires very close and regular follow-up because of the higher risk of cancer recurrence.

Alongside your father’s cancer treatment, supportive care will be very important to help him stay as strong and comfortable as possible during therapy.

This includes regularly monitoring his hemoglobin levels to keep track of anemia and fatigue, encouraging gentle physical activity as tolerated to help maintain muscle strength and reduce tiredness, ensuring he maintains good nutrition and proper hydration to support his body during treatment and recovery, and paying attention to his emotional well-being by managing stress and providing family support throughout this challenging time.

Please keep me updated if there are any changes in his symptoms or if you receive new test reports. Sharing lab results or imaging scans will help me give you more personalized advice. Many patients do well when treatment is started early with a structured plan, so try to stay hopeful and focus on each step of care.

I hope this helps.

Please revert in case of further queries.

Thank you.